The development and application of genetically engineered human serum albumin
- VernacularTitle:基因工程人血清白蛋白的研发与应用
- Author:
Yanhang GAO
1
;
Junqi NIU
1
Author Information
- Publication Type:Journal Article
- Keywords: Human Serum Albumin; Liver Diseases; Genetic Engineering
- From: Journal of Clinical Hepatology 2025;41(3):415-419
- CountryChina
- Language:Chinese
- Abstract: Human serum albumin （HSA） is the most abundant protein in plasma and has many biological functions and clinical applications. An adequate and stable supply of functional HSA molecules that are easy to store and have a long half-life is still an unmet clinical need. Therefore， it is extremely necessary to develop alternative methods for large-scale production of HSA. Genetic engineering techniques can clone the HSA gene into microorganism， animal， and plant hosts for efficient expression， which provides new possibilities for the large-scale production of HSA. This article reviews the advances in recombinant HSA （rHSA） in different expression systems and the production of rHSA by xenogeneic animals such as pigs and cattle， in order to draw attention to the application potential of genetic engineering techniques in HSA production and the importance of rHSA in the biomedical field in future.
